BMRN β€” BIOMARIN PHARMACEUTICAL INC

Ownership history in MQS Management LLC  Β·  7 quarters on record

This page tracks every 13F SEC filing in which MQS Management LLC reported a position in BIOMARIN PHARMACEUTICAL INC (BMRN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.34% (2024 Q2)
πŸ“Š Avg. % of fund
0.25%
πŸ“… First filed
2022 Q1
πŸ“… Last filed
2025 Q3
⏱ Quarters held
7

Position Intelligence

MQS Management LLC Γ— BMRN AI Analytics

πŸ“‰ MQS Management LLC underperformed the S&P 500 by –51.5% annually on this BMRN position. Timing score: 33% (2/6 decisions correct). Average cost basis: $79.10. Maximum drawdown during holding period: –44.3%.

πŸ“ˆ Position Alpha vs SPY
-51.5%
annualised excess return

❌ Significantly underperformed the S&P 500 by 51.5% ann.
6 quarters analyzed

⏱️ Timing Score
33%

⚠️ Poor timing β€” buys often preceded drops, trims preceded rallies.
2 of 6 add/trim decisions correct

πŸ’° Entry Quality
$79.10
-31.5% vs current ($54.16)

Best entry: $77.10 (2022 Q1)  Β·  Worst: $88.48 (2023 Q3)

πŸ›‘οΈ Drawdown Resilience
–44.3%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
43%
buy-side decisions

3 adds Β· 4 trims. Bought during 1 of 3 down-price quarters. πŸ“‰ Predominantly trimming β€” distribution phase.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.15% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    BMRN price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 7 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 4,614 -2,204 -32.3% 0.15% $250K $54.16
2024 Q2 ADDED 6,818 +2,803 +69.8% 0.34% $561K $82.33
2023 Q3 ADDED 4,015 +115 +2.9% 0.22% $355K $88.48
2023 Q2 REDUCED 3,900 -357 -8.4% 0.23% $338K $86.68
2023 Q1 REDUCED 4,257 -117 -2.7% 0.27% $414K $97.24
2022 Q2 REDUCED 4,374 -678 -13.4% 0.25% $362K $82.87
2022 Q1 INITIATED 5,052 β€” β€” 0.32% $390K $77.10

🏒 Other funds also holding BMRN

As of 2025 Q4 β€” sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 11.02% BOONE CAPITAL MANAGEMENT LLC 3Y 7.68% Palo Alto Investors LP 3Y 7Y 6.17% Vestal Point Capital, LP 6.06% Eagle Health Investments LP 3Y 4.79% Novo Holdings A/S 3Y 7Y 3.05% Soleus Capital Management, L.P. 3Y 2.89% SECTOR GAMMA AS 3Y 7Y 2.69% Deep Track Capital, LP 3Y 2.44% Sio Capital Management, LLC 3Y 7Y 2.18%
← Back to MQS Management LLC Holdings